Clinical Trial Update: A Long-term Follow-up Trial of Patients Previously Treated With Imlifidase Prior to Kidney Transplantation and a Non-comparative Transplanted Patient Group [Phase 3]

View source ↗

Summary

Phase 3 long-term follow-up trial evaluating imlifidase in patients treated before kidney transplantation, including a non-comparative transplanted group. The s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Imlifidase (imlifidase)

Snippet

Sponsor: Hansa Biopharma AB | Conditions: Long Term Efficacy and Safety | Phase 3 | Status: RECRUITING